Next Article in Journal
Platelet Distribution Width and Increased D-Dimer at Admission Predicts Subsequent Development of ARDS in COVID-19 Patients
Previous Article in Journal
Metabolomics and EMT Markers of Breast Cancer: A Crosstalk and Future Perspective
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Chronic Cannabis Intoxication and Propofol-Induced Salivation: Causes and Considerations

1
School of Medicine, LSU Health Sciences, Shreveport, LA 71130, USA
2
Division of Gastroenterology and Hepatology, LSU Health Sciences, Shreveport, LA 71130, USA
3
Department of Molecular and Cellular Physiology, LSU Health Sciences, Shreveport, LA 71130, USA
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Pathophysiology 2022, 29(2), 223-232; https://doi.org/10.3390/pathophysiology29020018
Submission received: 24 March 2022 / Revised: 16 May 2022 / Accepted: 19 May 2022 / Published: 28 May 2022

Abstract

Legalization/decriminalization of cannabis will increase the numbers of patients who have had recent exposure to recreational or medical cannabis. Currently, little has been reported about potential interactions between cannabis use and Propofol anesthesia e.g., for oropharyngeal procedures. We describe three cases of ‘cannabis-induced hypersalivation after propofol’ (CHAP) and present our institutions’ experience with this unique pharmacological combination. Increased hypersalivation may complicate procedures and represent a procedural risk of suffocation. We evaluate possible pharmacological interactions that might underlie this phenomenon and consider management options going forward.
Keywords: cannabis; propofol; hypersalivation; sedation cannabis; propofol; hypersalivation; sedation

Share and Cite

MDPI and ACS Style

Derise, A.; Ford, C.; Hafiz, N.; Pandit, S.; Vyas, A.; Igbinedion, S.; Morris, J.; Jordan, P.; Cai, Q.; Alexander, J.S. Chronic Cannabis Intoxication and Propofol-Induced Salivation: Causes and Considerations. Pathophysiology 2022, 29, 223-232. https://doi.org/10.3390/pathophysiology29020018

AMA Style

Derise A, Ford C, Hafiz N, Pandit S, Vyas A, Igbinedion S, Morris J, Jordan P, Cai Q, Alexander JS. Chronic Cannabis Intoxication and Propofol-Induced Salivation: Causes and Considerations. Pathophysiology. 2022; 29(2):223-232. https://doi.org/10.3390/pathophysiology29020018

Chicago/Turabian Style

Derise, Allison, Carey Ford, Nazar Hafiz, Sudha Pandit, Aditya Vyas, Samuel Igbinedion, James Morris, Paul Jordan, Qiang Cai, and Jonathan Steven Alexander. 2022. "Chronic Cannabis Intoxication and Propofol-Induced Salivation: Causes and Considerations" Pathophysiology 29, no. 2: 223-232. https://doi.org/10.3390/pathophysiology29020018

APA Style

Derise, A., Ford, C., Hafiz, N., Pandit, S., Vyas, A., Igbinedion, S., Morris, J., Jordan, P., Cai, Q., & Alexander, J. S. (2022). Chronic Cannabis Intoxication and Propofol-Induced Salivation: Causes and Considerations. Pathophysiology, 29(2), 223-232. https://doi.org/10.3390/pathophysiology29020018

Article Metrics

Back to TopTop